GAMMA Investing’s Perspective Therapeutics CATX Stock Holding History

GAMMA Investing’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.81K	Buy	659 +319	+94%	+$967	﹤0.01%	3975
2026 Q2	$1.16K	Sell	340 -246	-42%	-$929	﹤0.01%	3850
2026 Q1	$2.44K	Buy	586 +391	+201%	+$1.65K	﹤0.01%	3600
2025 Q4	$536	Buy	+195	New	+$556	﹤0.01%	3906
2025 Q1	–	Sell	-64	Closed	-$204	–	3811
2024 Q4	$204	Buy	64 +46	+256%	+$376	﹤0.01%	3703
2024 Q3	$240	Buy	+18	New	+$239	﹤0.01%	3476

Other funds holding CATX

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $208M AUM 15.78% 1-Year Est. Return

ISB

Iowa State Bank Urbandale, Iowa $592M AUM 21.15% 1-Year Est. Return

GAMMA Investing's CATX Position: Q3 2026 in Review

GAMMA Investing increased its Perspective Therapeutics (CATX) stake by 94% in Q3 2026, buying an estimated $967 and bringing the position to 659 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #3975.

GAMMA Investing first reported a position in CATX in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.44K in Q1 2026. 3 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

GAMMA Investing held 659 shares of Perspective Therapeutics worth $1.81K as of Q3 2026.
GAMMA Investing bought 319 Perspective Therapeutics shares in Q3 2026, an estimated $967.
Perspective Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3975 holding.
GAMMA Investing first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 6 quarters since.
GAMMA Investing's Perspective Therapeutics position peaked at $2.44K in Q1 2026.
3 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.